 |
1-{2-[3-(3,4-Dichlorophenyl)ureido]-6-methyl-pyrimidin-4-yl}-amino-3(dimethylamino)propane Di methansulfonate |
|---|---|
| Trade Name | |
| Orphan Indication | Glioma |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-02 00:00:00 |
| Sponsor | Curtana Pharmaceuticals, Inc.;1624 Headway Circle;Austin, Texas, 78754 |
Related Access Program